vimarsana.com

Page 11 - வர்த்தகம் தொடர்புடையது அறிவுசார் ப்ராபர்டீ உரிமைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Greed triggers gross vaccine inequality

556 Essential: The IPR waiver can easily expedite the mass production of generics, making them cheaply available. Reuters Devinder Sharma Food & Agriculture Specialist This is disturbing. With only one-in-500 among the low-income countries having received the vaccine shot against one-in-four among the high-income countries, gross vaccine inequality has been at play. As per the World Health Organisation (WHO), poor countries have received only 0.2 per cent of the vaccine doses while the rich countries have walked away with a share of 87 per cent. So far, only 32 per cent in America, 27 per cent in the UK, 2 per cent in India and 0.3 per cent of the population in the Philippines have received both doses. At this rate, it may take years before the world can emerge out of the pandemic. The rich need to understand they cannot remain safely isolated from the deadly virus till the poor too have got the protective shield.

U S to support intellectual property waiver for COVID-19 vaccines

United States Trade Representative (USTR) Katherine Tai. File   | Photo Credit: AFP The news will support the increased production of vaccines globally as countries, including India, continue to reel under the impact of the pandemic. The United States will support an initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) protection for COVID-19 vaccines, the Biden administration said on Wednesday. The news will support the increased production of vaccines globally as countries, including India, continue to reel under the impact of the pandemic. The initiative was first floated by India and South Africa last October.

COVID-19 | US support for waiving vaccine patents, India s role and other questions answered

COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered Gaurav Choudhury © Gaurav Choudhury COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered On May 5, the United States said that it will support an initiative at the World Trade Organisation (WTO) for a temporary waiver of Trade Related Intellectual Property Rights (TRIPS) protection for Covid-19 vaccines.  Here’s a lowdown. Why is it a big deal? This would help quickly ramp up the production of Covid-19 vaccines across the world. The US’s move will help rally support for temporarily removing patents on Covid-19 vaccines and making these eligible for production by drugmakers across the world.

Morning Digest — May 6, 2021 - The Hindu

Updated: A select list of stories to read before you start your day. Share Article AAA Workers clearning railway coaches converted into Covid-19 isolation wards at the Sabarmati Station in Ahmedabad on Wednesday May 5, 2021.   | Photo Credit: VIJAY SONEJI A select list of stories to read before you start your day. The current COVID-19 surge in India may begin to start tapering between the middle and end of May, virologist Gagandeep Kang said on Wednesday. At a virtual interaction with members of the Indian Women Press Corps, Dr. Kang said, “Best guess estimates from a number of models put this somewhere between the middle and end of the month. Some models have it [second wave] going out in early June. Based on what we are seeing now, middle to end of May would be a reasonable estimate.”

Biden undecided on COVID-related TRIPS waiver, as Republican lawmakers oppose India s proposal at WTO

U.S. Trade Representative Katherine Tai. File photo   | Photo Credit: REUTERS 12 Republican lawmakers write a seven-page letter to U.S. Trade Representative Katherine Tai on the issue U.S. President Joe Biden said on Tuesday that he had not made a decision on whether the U.S. would support an Indian and South African initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) to facilitate the production of COVID-19 related vaccines and therapeutics around the world. “Well, we’re going to decide that as we go along, I haven’t made that decision yet,” Mr. Biden said on Tuesday afternoon at the White House, after he delivered remarks on the U.S.’s vaccination campaign. His administration would move as quickly as possible to get as many doses of Pfizer and Moderna’s vaccines to export to the rest of the world, Mr Biden said. The U.S. government has already ordered 100 million additional doses of these vaccines through

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.